Yuki Gosei Kogyo Co., Ltd. (TYO:4531)

Market Cap	5.36B
Revenue (ttm)	14.85B
Net Income (ttm)	891.00M
Shares Out	21.54M
EPS (ttm)	41.01
PE Ratio	6.07
Forward PE	n/a
Dividend	9.00 (3.70%)
Ex-Dividend Date	Mar 28, 2025

Volume	130,900
Average Volume	72,995
Open	246.00
Previous Close	243.00
Day's Range	243.00 - 260.00
52-Week Range	214.00 - 316.00
Beta	0.56
RSI	49.59
Earnings Date	May 15, 2025

About Yuki Gosei Kogyo

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmac...

• Industry: Chemicals
• Sector: Materials
• Founded: 1947
• Employees: 290
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4531

Financial Performance

In 2023, Yuki Gosei Kogyo's revenue was 12.93 billion, an increase of 0.72% compared to the previous year's 12.84 billion. Earnings were 776.00 million, an increase of 39.57%.